Dr. Alex Tatem is a board-certified urologist and one of the most-followed men's health voices on YouTube. His channel boasts more than 200,000 subscribers with over 14 million views, and has become the place people come to understand testosterone, peptides, and performance medicine. Dr. Alex reads the research and pairs it with something rarer: experience gained from treating thousands of patients with his own hands in both the clinic and operating room. Audiences get the real answer, grounded in what actually works.
Dr. Alex has given more than 100 talks and presentations and published more than 25 peer-reviewed papers. He's previously co-authored the American Urological Association's Core Curriculum on testosterone deficiency, and currently runs one of the busiest men's health surgical practices in the country.
For journalists and producers:Dr. Alex takes press calls on testosterone and hormone therapy, peptides and compounding, GLP-1s and metabolic medicine, erectile dysfunction and sexual health, male fertility, and men's health policy. He is comfortable on the record, moves fast on deadline, and can go broadcast-quality remote from his studio in Indianapolis. Reach him directly at alextatemmd@gmail.com. Past appearances are here.
Want him at your next corporate wellness event, medical conference, panel, or podcast? Click here to check his availability.
Keynote presentations and panel discussions tailored for medical societies, executive health forums, and corporate wellness programs.
Men's health is in the middle of the biggest shift it has ever had. Testosterone therapy has moved from the fringe into mainstream guideline-driven care, and metabolic medicine now has tools that genuinely work. Dr. Alex has spent his career inside that shift, treating these patients daily and co-authoring the national curriculum that trains urologists on testosterone deficiency. He shows audiences what the evidence supports right now, and how much further it reaches than most of them expect.
From peptides to stem cells, exosomes to hormone therapy, longevity medicine is moving faster than most of medicine can track it. Dr. Alex has testified before the FDA and worked directly on the regulatory questions shaping access to peptides and personalized medications, a vantage point almost no practicing clinician has. He separates what the evidence already supports from what is still a promise, and lays out where the rules are heading for prescribers, pharmacies, and suppliers.
Patients now arrive with a diagnosis, a protocol, and a creator they trust more than their physician. Dr. Alex works both sides of that, operating full time while reaching more than 200,000 subscribers and 14 million views on YouTube. What social media gets right about health, where it goes wrong, and how physicians and health systems earn attention without spending their credibility.
Independent practice is being reshaped on a scale no one in medicine was trained for. Dr. Alex lived it, starting in pure private practice and coming out the other side of two capital transactions, and he now serves as corporate director of men's health for the national platform his group joined. A direct look at consolidation, cash-pay, and what physicians actually own versus what they only rent.
Dr. Alex's verified media features, podcast episodes, clinical articles, and society keynotes.
Dr. Tatem explains on Fox why the federal peptide hearings were mandated and argues that years of patient use show a promising safety profile. Published July 28, 2026 — featured on Fox's homepage and syndicated to Yahoo News.
Dr. Tatem is featured as the physician working with patients to restore health after SARMs use. Aired October 2024 alongside journalist Steven Romo. Confirmed via Urology of Indiana announcement (Nov 27, 2024).
KTLA 5's 'Off the Clock' segment (June 10, 2026): separating fact from fiction on peptides for weight loss, muscle recovery, and anti-aging — live on Los Angeles television.
Released April 20, 2026 (~1 h 30 min). DOAC bills Dr. Tatem as 'an internationally recognised urologist who has studied peptides for 12 years and runs a men's health clinic.' One of the biggest podcasts on earth. Available on Spotify and Apple Podcasts.
May 18, 2026 (~56 min). Australian TV host Karl Stefanovic sits down with Dr. Tatem on peptides, testosterone decline, obesity, male fertility, and the future of preventative men's health.
Post-PCAC vote episode (July 2026): the FDA committee's 6-of-7 peptide recommendation and what national media coverage missed. Dr. Tatem is the featured guest, breaking down BPC-157, TB-500, KPV, MOTS-c, Semax, and Epitalon.
January 7, 2025 — with Kristen Gumpf, PA-C, hosted by Dr. Jose Silva. Dr. Tatem discusses how advanced practice providers are reshaping high-volume men's health surgical and clinical workflows.
May 2025, hosted by Amy Pearlman, MD. Dr. Tatem navigates real-world testosterone replacement therapy from evidence-based guidelines to individualized patient outcomes. Announced May 21, 2025 by Urology of Indiana.
Early 2026 — Dr. Tatem joins Drs. Pearlman and Lipshultz on the 'Fertility and Other F Words' podcast to discuss hyaluronic acid penile filler procedures, patient selection, and safety. Episode announced by Dr. Tatem via LinkedIn.
Hosts Drs. Kevin Chu & Justin Dubin take a deep dive with Dr. Tatem on the clinical reality of anabolic steroid use — risks, restoration protocols, and what urologists actually see in practice.
Dr. Tatem cuts through the noise on peptides, testosterone replacement therapy, and male enhancement — what the evidence supports, what is hype, and how to have an honest conversation with your physician.
July 2026 — Dr. Tatem (identified as a member of Rugiet's Medical Advisory Board) previews all seven peptides under FDA PCAC review — BPC-157, KPV, TB-500, MOTS-c, Semax, Epitalon, and emideltide (DSIP) — and their safety profiles.
May 21, 2026 — Dr. Tatem on the explosive peptide market boom that threatens Big Pharma GLP-1 brands and the regulatory vacuum the FDA is scrambling to fill. Syndicated to Yahoo News, WFMD, and 1010 WCSI.
July 28, 2026 — The FDA's PCAC voted 6-of-7 to recommend BPC-157, KPV, TB-500, MOTS-c, Semax, and Epitalon for the 503A Bulks List — overruling FDA scientists. Dr. Tatem is quoted as a peptide expert in the post-vote wrap.
December 2021 — Dr. Tatem explains the ~1%/year testosterone decline in aging men, the clinical reality of andropause, and warns against subscription 'low-T clinics' that skip proper diagnostics.
November 2021 — Dr. Tatem explains the mechanics of the tunica albuginea, how sex position affects penile fracture risk, and the correct clinical response if it happens.
April 13, 2020 — Journalist Mark Hay quotes Dr. Tatem, described as 'an Indianapolis-based reproductive urologist,' on the pandemic surge in sperm banking inquiries and the medical reality behind male fertility anxiety during COVID-19.
December 23, 2021 — Journalist Varuna Srinivasan quotes 'Indiana urologist Alexander Tatem' debunking a viral TikTok claim. Dr. Tatem notes sperm is <5% of semen volume and explains what semen allergy actually is.
~February 2026 — A four-part Urology Times editorial video series: (1) safety & risks interview, (2) short safety overview, (3) science explainer, and (4) warning on non-medical filler injections. Full author hub at urologytimes.com/authors/alex-tatem.
FIU Caplin News covers the FDA Pharmacy Compounding Advisory Committee hearing (Docket FDA-2025-N-6895, July 23–24, 2026) with a video story. Quotes Dr. Tatem at length on being unable to prescribe peptides under 2023 restrictions and patients turning to unvetted overseas sources.
Whether you need a keynote speaker, panel expert, podcast guest, or media source — our team will coordinate availability within 48 hours.
